Financials

  • Market Capitalization 356.84 M
  • Employee 149
  • Founded 2018
  • CEO N/A
  • Website www.kyvernatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RCYMHR1
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.58
Fiyat/satışlar oranı
-6 934.07

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3081
RLMD
Relmada Therapeutics, Inc. - Common Stock
3.36 USD-4.27%+3.07%-24.32%+74.09%358.41 M USD
3084
FENC
Fennec Pharmaceuticals Inc. - Common Stock
10.18 USD-5.04%-0.29%-3.96%+22.06%356.98 M USD
3099
IRD
Opus Genetics, Inc. - Common Stock
4.24 USD-8.62%-1.85%-28.62%+13.98%352.75 M USD
3121
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
5.72 USD-3.21%-1.21%-4.67%+57.58%343.80 M USD